About $74 million in US govt funding (including NIH) went into developing enzalutamide - a multibillion dollar drug that prolonged life for countless men with prostate cancer. Why would anyone cut this support? We need more, not less! @ascocancer.bsky.social @theaacr.bsky.social
23.02.2025 19:11 — 👍 12 🔁 6 💬 1 📌 0
Comparison of Adjuvant regimens for cancer across tumor types #GU25. Nivolumab per Checkmate 274 for #bladdercancer rises to the top. docs.google.com/presentation...
15.02.2025 15:36 — 👍 6 🔁 3 💬 0 📌 0
Would love to be included Tian. Thanks for organizing!
04.02.2025 04:32 — 👍 1 🔁 0 💬 1 📌 0
MD/PhD, GU Oncologist, Purdue and UNC alumna, she/her, opinions are my own
GU Oncologist & PD @ UIC | 🇨🇦 GU & NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | Two Onc Docs podcast
Oncology Research Bioengineer 🧪 Bandleader in Biotech 🪩🥁🎺🪇🎷🎹
-Kidney cancer patient ➡️ Advocate
-Stage 2b ccRCC
-Youngest person in the urology office by 30 years 🤪
#Cansky #Kidneycancer #Oncsky | #Photography | #Music
The Australian and New Zealand Urogenital and Prostate cancer trials group aims to develop, foster and promote prostate and other urogenital cancer research.
Urologic oncologist at University of Wisconsin | surgeon-scientist studying kidney cancer
Chief Clinical Officer, City of Hope Chicago
Urologic Oncologist at @VanProstateCtr and @UBCUrology. Editor-in-chief @SIU_Journal
Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Kohberg Professor of Medicine, Harvard Medical School
Online Tumor Board with a molecular angle ~ Join us every Tuesday 8pm ET for discussions, polls, & mini tweetorials
Created by @mpishvaian.bsky.social • @MPishvaian • FREE CME
Professor of Medicine and Biostatistics at Brown University, Director of the Center for Clinical Cancer Informatics and Data Science (CCIDS), CTO of HemOnc.org, co-founder of the COVID-19 and Cancer Consortium (CCC19), EIC of JCO CCI. Views my own.
Jack Lapides, M.D., Research Professor and Chief of Urologic Oncology University of Michigan; Co-Director Weiser Center for Prostate Cancer
GU oncologist, Interested in precision oncology. ADC biomarker development. NECTIN4. Clinician Scientist. PI of translational research group at the University Hospital Bonn. Opinions are my own
Stage IV kidney cancer (metastatic oncocytoma) | Software Developer | Founder of COA | Obsessed w/podcasts, medical science & nonfiction | Memoir - Too Young For Cancer | Views own
https://www.katiekickscancer.com
Leading global efforts to improve access to cancer care. Advancing education, research, and innovation in hematology & oncology.
📍 Cancer hospitals in Nepal
🎓 CME & conferences worldwide
📅 Join us: https://binaytara.org
#CancerCare #HealthEquity
The KCA is a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education.
